As a practicing physician who has cared for patients with Alzheimer’s disease and other dementias for more than two decades, ...
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
BrainSpec, the comprehensive software platform enabling virtual biopsies of the brain, has been awarded clearance by the FDA to begin using their Magnetic Resonance Spectroscopy (MRS) platform to ...
The U.S. Food and Drug Administration has rejected a drug made by a Lexington biotech just a few months after it rejected ...
FDA approves much-debated Alzheimer’s drug panned by experts June 8, 2021 Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus November 30, 2022 Panel: More ...
Nov. 21, 2023 — A team of researchers employed hearing tests and magnetic resonance imaging (MRI) to determine whether hearing impairment is associated with differences in specific brain regions ...
Alzamend Neuro Inc (NASDAQ: ALZN) has received a "Study May Proceed" letter from the FDA for the initiation of study ...
The blockbuster weight loss drug Wegovy has a new rival. Today, the US Food and Drug Administration approved a new drug for weight management called Zepbound, made by American pharmaceutical ...
A new poll from the University of Michigan confirms that older adults will take results seriously: Ninety-seven percent of ...
If you’re looking for a natural and effective alternative to prescription adderall medication, this guide is for you.
A doctor looks at a PET brain scan at the Banner Alzheimer's Institute in Phoenix in this Aug. 14, 2018, file photo. (AP/Matt York, File) It's the first drug proven to slow the progression of ...
This week's Lab Notes has items on a multimillion-dollar debt financing, a manufacturing deal, a new director hire at CHOP, a positive study for a medical device and more. Here’s the roundup ...
